RELA and breast carcinoma: To further validate that the transcriptional activity of RelA in ER+ breast cancer cells is nearly restricted to HD conditions, we silenced RelA with CRISPR-Cas9 using two different single guide RNAs (gRNA; Supplementary Fig. S6I and S6J).